ACET Adicet Bio, Inc.

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cells therapies for cancer and other diseases.

$9.82  -0.53 (-5.12%)
As of 12/03/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/26/2018
Outstanding shares:  31,955,450
Average volume:  184,790
Market cap:   $330,738,908
Current dividend yield:  7.43%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    007002108
ISIN:        US0070021086
Sedol:      BMC5RV6
Valuation   (See tab for details)
PE ratio:   -5.68
PB ratio:   1.44
PS ratio:   34.20
Return on equity:   -25.39%
Net income %:   -570.14%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy